Gartner Research

Ortems Wins Pharmaceutical Account

Published: 09 June 2000

ID: G00190425

Analyst(s): Roddy Martin


Ortems Direct Inc., the Advanced Planning and Scheduling (APS) vendor specializing in process manufacturing, has been selected as the plant scheduling system at Geneva Pharmaceuticals Inc. a business unit of Novartis AG. Ortems was selected to augment the SAP R/3 ERP and APO supply chain backbone. Geneva Pharmaceuticals anticipates certified integration to SAP products via the Planning Optimizer Interface (POI) to be live in 2000. The plan is to eventually roll out to 40 sites. Ortems also reports that another leading pharmaceutical manufacturer is looking to use Ortems instead of SAP APO at the plant level.

©2021 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.